Umbilical Cord Tissue-derived Mesenchymal Stem Cells Should be Considered as Adjuvant Therapy for COVID-19 Treatment: An Opinion from Pooled Clinical Evidence. Biomed. Res. Ther. [Internet]. 2021 Sep. 30 [cited 2024 Nov. 15];8(9):4583-95. Available from: https://preservation.bmrat.org/index.php/BMRAT/article/view/694